Knowledge hub

Drug Discovery

Scientist analyzing high-content cell images on a computer screen – visualizing AI-driven phenotypic profiling in drug discovery.
Blog

The Future of Drug Discovery: Integrating Phenotypic Data with Omics and AI

a biopharma lab
What’s trending in European Biopharma? A look ahead
banner that introduces blog post a key take aways from the Drug Discovery Conference
Data dreams and drug design: What we learned at Discovery and Development Europe 2025
BIO Convention 2025
BIO International Convention 2025 – New Standards in Collaboration, Innovation, and the Integration of AI in Biotechnology
Biologics 2.0 – From monoclonal antibodies to multispecific therapeutics
High-performance computing servers powering biomedical data pipelines and drug discovery.
Beyond the Petabytes: What It Really Takes to Power the Next Leap in Drug Discovery
Ardigen co-organizes CVPR 2025 workshop on Computer Vision for Drug Discovery
Two scientists observing AI-driven cell analysis on a digital screen, representing decision-making in biotech innovation.
Build or Buy? Strategic Considerations for Biotech Companies Implementing AI Solutions
biotech US market
AI in biotech: What the US market got right (and what it’s still learning)
an Majta presenting on AI and omics data in drug discovery at NextGen Omics Conference 2025.
Blog

From Data Chaos to Drug Discovery – Ardigen Talk at NextGen Omics Conference

BioIT 2025 insights
AI, Genomics and the Future of Medicine: Highlights from Bio-IT World Conference & Expo 2025
optimization strategies for scalable bioinformatics workflows.
The Scaling Paradox: Why Adding More Cloud Resources in Bioinformatics Doesn’t Always Solve the Problem
nextgen omics 2025
Insights from NextGen Omics 2025
The role of AI CROs in the next wave of biopharma transformation)
AI CROs and the Pharma Shift: The Next Wave of Drug Discovery Innovation